-+ 0.00%
-+ 0.00%
-+ 0.00%
Is Alm. Brand (CPSE:ALMB) Cheap As Raised Guidance Meets A Full P/E?
Share
Listen to the news

Alm. Brand (CPSE:ALMB) raised its 2026 insurance service result guidance on 5 October after a favourable third quarter, lifting the range by DKK 250 million to DKK 1.5 to 1.6 billion.

The raised guidance lands against a softer share price backdrop, with Alm. Brand changing hands at DKK16.2 after the stock fell about 5.9% over the past month and declined 12.9% on a year to date share price basis, yet still delivering a 3 year total shareholder return of 74.2% and 5 year total shareholder return of 58.6%. This points to longer term momentum that recent volatility and this year’s pullback have not fully erased.

Scan insurers facing similar guidance shifts to Alm. Brand by focusing on curated 225 resilient stocks with low risk scores that pair resilient balance sheets with controlled risk profiles.

Guidance is moving up while Alm. Brand’s share price has moved the other way. The crucial issue now is whether the real upside still lies ahead or if most of it already sits in the price.

Most Popular Narrative: 18% Undervalued

Against Alm. Brand’s last close at DKK16.2, the most followed valuation narrative points to a fair value of DKK19.7. This frames the upgraded 2026 guidance in the context of a wider earnings and capital return story.

Successful synergy initiatives have already exceeded targets in 2024, with expectations to reach DKK 600 million in 2025. This operational efficiency is likely to boost earnings and improve cost structures.

See why 10 investors see Alm. Brand as 18% undervalued.

Result: Fair Value of DKK19.7 (UNDERVALUED)

Still, that narrative cracks quickly if Alm. Brand’s near 100% payout ratio constrains reinvestment or if intense Danish non life competition erodes profitability faster than expected.

Find out about the key risks to this Alm. Brand narrative.

Another View On Alm. Brand’s Valuation

The earlier narrative leans on cash flows and fair value at DKK19.7. Look at Alm. Brand through its P/E instead and the picture changes. The stock trades on about 24.6x earnings, roughly double the European insurance average of 12.3x and above a peer group on 11x.

The fair ratio sits at 24.8x, almost identical to where Alm. Brand trades today. That suggests limited room for error if earnings forecasts or sentiment weaken. When one method flags undervaluation and another hints at a fully priced multiple, which one do you trust more?

See what the numbers say about this price — find out in our valuation breakdown.

CPSE:ALMB P/E Ratio as at Oct 2026
CPSE:ALMB P/E Ratio as at Oct 2026

Next Steps

If this combination of upgraded guidance and a seemingly full P/E leaves you uncertain, take prompt action and evaluate the numbers yourself from both perspectives. To assess those cross currents directly, start with the balance of 3 key rewards and 2 important warning signs

Looking for more ideas beyond Alm. Brand?

If Alm. Brand has sharpened your focus on valuation and risk, do not stop here. Broaden your opportunity set and pressure test your thinking across fresh watchlist candidates.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending